Hi sudheendra,
It’s been long time since you updated here. Can you please post your recent pf and share how it performed since last few yrs?
Regards
Narayana
Still far away from achieving my goal of having 85% allocation in 10 stocks 
May be getting more comfortable in diversification in this market. Also considerable changes to portfolio as below over last 1.5 years.
Hold - Avanti, PI, Shilpa, Ajanta, Page, Symphony (5%-13 % each)
Exits - Kitex, Cera (Repenting now), Repco (Repenting now), MPS, Anuh, Mayur, Premco, Atul Auto, Control Print
Additions - Sun, Suzlon, Bajaj Fin, GIC, Edelweiss, Manapuram, JHS, Pokarna, Voltamp, Nesco, Ultramirine, Bodal, Indian Toners, IDFC Bk, Vikas eco ( 3%-5% each)
In summary more allocation to finance and chemicals and turnarounds(hopefully). In general Pharma under performed which had good allocation. Still learning the art of portfolio allocations and catching the industry trends early.
Overall returns - for last 1 year - it his inline with Midcap/smallcap index. Over last 4 years, it has has beaten these indexes quite well.
Br, Sudheendra
3 Likes
Interested to know your logic for buying into Edelweiss and JHS ?
JHS - Bet on re-rating with consumption sector led possible growth opportunities with large clients like Pathanjali, Dabur, Colgate in the oral care sector. No capex needs for short-term, debt free, foray into branded FMCG play along with existing contract manufacturing for large clients.More importantly there were indications of management learning from past mistakes and taking right actions now. Also recently they settled ongoing dispute with P&G and it was positive for JHS.
Edelweiss - Good and ambitious management capable of taking advantage of adjacent opportunities in financial services sector. Looks all set for good growth in next 3-5 years.
Br, Sudheendra
1 Like